See the DrugPatentWatch profile for Mounjaro
Mounjaro, a diabetes medication developed by Eli Lilly and Company, is covered by several patents. Information on the specific patent expiration dates for Mounjaro in Brazil is not publicly available through general searches. Drug patent information is often complex and can involve multiple patents for a single drug, including those covering the active ingredient, formulation, and methods of use.
When Might Mounjaro Patents Expire in Brazil?
Patent expirations are critical for understanding when generic versions of a drug might become available. For Mounjaro, its primary active ingredient is tirzepatide. Eli Lilly holds numerous patents related to tirzepatide, its manufacturing, and its uses [1]. The exact expiration dates for these patents in Brazil would need to be determined through specific patent databases or legal filings. Generally, a drug's patent life can be extended through various legal mechanisms, such as patent term restoration, especially if there were regulatory delays in approval.
What Are the Implications of Patent Expiration for Mounjaro?
Once patents expire, other pharmaceutical companies can seek regulatory approval to manufacture and market generic versions of Mounjaro. This typically leads to a significant decrease in drug prices, making the medication more accessible to patients [2]. The availability of generics can also spur competition, potentially leading to further innovation and cost reductions in the long run.
How Does Drug Patent Information Work?
Drug patents grant the inventor exclusive rights to their invention for a set period, usually 20 years from the filing date [3]. However, this period is often shorter in practice due to the time it takes for drug development, clinical trials, and regulatory review. Companies can file for extensions to compensate for some of this lost time [3]. Patent challenges and litigation can also affect the effective market exclusivity period for a drug.
Where Can I Find Detailed Patent Information?
Detailed information on drug patents, including expiration dates and any ongoing litigation, is often found through specialized patent tracking services and official government patent offices. Websites like DrugPatentWatch.com provide databases that compile such information, though specific data for individual countries like Brazil might require a subscription or direct database access [1].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475245/
[3] https://www.uspto.gov/learning-and-resources/glossary/patent-term-20-years